Gabrielle E. Foxa - Concepedia

Author

Gabrielle E. Foxa

Van Andel Institute ORCID

Also Known As

Gabrielle E Foxa, Gabrielle E. Foxa, Gabrielle Foxa

Publications

377

Citations

H-Index

Concepts

All Affiliations

Van Andel Institute Hospital for Special Surgery Indiana University School of Medicine Boston Children's Hospital Harvard University

About

Gabrielle E. Foxa is an author at Van Andel Institute specializing in medicine, cell biology, and bone metabolism.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	154
2	Cell Biology	3	3	57
3	Health Sciences	2	2	110
4	Endocrinology	1	1	13
5	Pharmacology	1	1	97

Gabrielle E. Foxa

Publications

362

Citations

H-Index

Page 1

	Year	Citations
An osteocalcin-deficient mouse strain without endocrine abnormalities Cassandra R. Diegel, Steven Hann, Ugur M. Ayturk, PLoS Genetics	2020	123
Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy Babita Madan, Mitchell J. McDonald, Gabrielle E. Foxa, Bone Research Bone DiseaseBone LossBone HealthMetabolic Bone DiseaseMedicine	2018	97
LRP1 Suppresses Bone Resorption in Mice by Inhibiting the RANKL-Stimulated NF-κB and p38 Pathways During Osteoclastogenesis Di Lü, Jianshuang Li, Huadie Liu, Journal of Bone and Mineral Research	2018	31
Androgen receptor splice variants drive castration-resistant prostate cancer metastasis by activating distinct transcriptional programs Dong Han, Maryam Labaf, Yawei Zhao, Journal of Clinical Investigation Androgen ReceptorTranscriptional RegulationUrologySomatic VariantSclerostin	2024	31
Frizzled‐4 is required for normal bone acquisition despite compensation by Frizzled‐8 Priyanka Kushwaha, Soo‐Hyun Kim, Gabrielle E. Foxa, Journal of Cellular Physiology	2020	27
Low-Density Lipoprotein Receptor–Related Protein 5–Deficient Rats Have Reduced Bone Mass and Abnormal Development of the Retinal Vasculature John L. Ubels, Cassandra R. Diegel, Gabrielle E. Foxa, The CRISPR Journal	2020	15
Mithramycin induces promoter reprogramming and differentiation of rhabdoid tumor Maggie H. Chassé, Benjamin K. Johnson, Elissa A. Boguslawski, EMBO Molecular Medicine Tumor BiologyMedicineRhabdoid TumorTumor SuppressorCancer Biology	2020	13
Inhibiting WNT secretion reduces high bone mass caused by Sost loss-of-function or gain-of-function mutations in Lrp5 Cassandra R. Diegel, Ina Krämer, Charles Moes, Bone Research SclerostinHigh Bone MassOsteoporosisBone Morphogenic ProteinOsteoarthritis	2023	13
An Osteocalcin-deficient mouse strain without endocrine abnormalities Cassandra R. Diegel, Steven Hann, Ugur M. Ayturk,	2019	12

Page 1